Wilhelmus J Kwanten
Wilhelmus J Kwanten is an expert in Hepatology at Antwerp University Hospital (Belgium). Wilhelmus J Kwanten has authored 76 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 296 (community average: 125). How the SLR is computed.
LeadR Profile
Hepatology
Subspecialties: Gastroenterology - Cardiology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2014 - 2026
Number : 76
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Hepatic venous pressure gradient, non-invasive tests, and prognosis across the subtypes of advanced steatotic liver disease. PMID 42276315 — liver diseases, hypertension, mortality, non-alcoholic fatty liver disease, venous pressure, liver, hypertension, portal, prognosis | Clin Gastroenterol Hepatol | 2026 | 0 |
| Plasma cell-free transcriptome profiling in blood plasma from chronic liver disease patients. PMID 42173964 — liver diseases, cells, gene expression profiling, blood, transcriptome, plasma cells, liver, plasma | Sci Data | 2026 | 0 |
| SBP: Always peritonitis in decompensated cirrhosis? Case report and review of the literature. PMID 41493324 — peritonitis, gastroenterology, pericardial effusion, pericarditis, therapeutics | Acta Gastroenterol Belg | 2025 | 0 |
| Predicting hepatic decompensation using non-invasive tests in a contemporary multicentre cohort of patients with cACLD. PMID 41192692 — liver diseases, hypertension, non-alcoholic fatty liver disease, venous pressure, liver, hypertension, portal, ascites, liver stiffness | J Hepatol Top journal | 2025 | 0 |
| Altered liver sinusoidal endothelial cells in MASLD and their evolution following lanifibranor treatment. PMID 40486133 — liver diseases, cells, portal pressure, fibrosis, vascular resistance, non-alcoholic fatty liver disease, liver, peroxisomes, endothelial cells, therapeutics, peroxisome proliferator-activated receptors | JHEP Rep | 2025 | 0 |
Clinical Studies 1
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
LeadR Networks
Main global connection map